argenx to Present at Upcoming Investor Conferences
argenx (Euronext & Nasdaq: ARGX), a global immunology company, has announced its management team's participation in three major healthcare conferences this December. The schedule includes presentations at Citi's 2024 Global Healthcare Conference in Miami (December 3), the 7th Annual Evercore I&I HealthCONx Conference in Coral Gables (December 4), and Piper Sandler's 35th Annual Healthcare Conference in New York (December 5). All presentations will be fireside chats, with additional information available on the company's investor relations website.
argenx (Euronext & Nasdaq: ARGX), un'azienda globale nel settore dell'immunologia, ha annunciato la partecipazione del suo team di gestione a tre importanti conferenze sanitarie questo dicembre. Il programma prevede presentazioni alla Citi's 2024 Global Healthcare Conference a Miami (3 dicembre), alla 7th Annual Evercore I&I HealthCONx Conference a Coral Gables (4 dicembre) e alla Piper Sandler's 35th Annual Healthcare Conference a New York (5 dicembre). Tutte le presentazioni saranno in forma di colloqui informali, con ulteriori informazioni disponibili sul sito web delle relazioni con gli investitori dell'azienda.
argenx (Euronext & Nasdaq: ARGX), una empresa global de inmunología, ha anunciado la participación de su equipo directivo en tres importantes conferencias de salud este diciembre. El programa incluye presentaciones en la Citi's 2024 Global Healthcare Conference en Miami (3 de diciembre), la 7th Annual Evercore I&I HealthCONx Conference en Coral Gables (4 de diciembre) y la Piper Sandler's 35th Annual Healthcare Conference en Nueva York (5 de diciembre). Todas las presentaciones serán charlas informales, y se podrá encontrar información adicional en el sitio web de relaciones con los inversores de la empresa.
argenx (Euronext & Nasdaq: ARGX)는 글로벌 면역학 회사로서, 이번 12월에 경영진이 3개의 주요 의료 회의에 참석한다고 발표했습니다. 일정에는 마이애미에서 열리는 Citi's 2024 Global Healthcare Conference (12월 3일), 코럴 게이블스에서 열리는 7th Annual Evercore I&I HealthCONx Conference (12월 4일), 뉴욕에서 열리는 Piper Sandler's 35th Annual Healthcare Conference (12월 5일)의 발표가 포함됩니다. 모든 발표는 화로 앞 대화 형식으로 진행되며, 추가 정보는 회사의 투자자 관계 웹사이트에서 확인 가능합니다.
argenx (Euronext & Nasdaq: ARGX), une entreprise mondiale en immunologie, a annoncé la participation de son équipe de direction à trois grandes conférences de santé ce décembre. Le calendrier inclut des présentations à la Citi's 2024 Global Healthcare Conference à Miami (3 décembre), à la 7th Annual Evercore I&I HealthCONx Conference à Coral Gables (4 décembre) et à la Piper Sandler's 35th Annual Healthcare Conference à New York (5 décembre). Toutes les présentations se feront sous forme de discussions informelles, avec des informations supplémentaires disponibles sur le site des relations investisseurs de l'entreprise.
argenx (Euronext & Nasdaq: ARGX), ein globales Unternehmen im Bereich Immunologie, hat die Teilnahme seines Management-Teams an drei wichtigen Gesundheitskonferenzen im Dezember angekündigt. Der Zeitplan umfasst Präsentationen auf der Citi's 2024 Global Healthcare Conference in Miami (3. Dezember), der 7th Annual Evercore I&I HealthCONx Conference in Coral Gables (4. Dezember) und der Piper Sandler's 35th Annual Healthcare Conference in New York (5. Dezember). Alle Präsentationen werden in Form von informellen Gesprächen gehalten, wobei zusätzliche Informationen auf der Investor-Relations-Website des Unternehmens verfügbar sind.
- None.
- None.
November 26, 2024
Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following upcoming investor conferences in December.
- Citi’s 2024 Global Healthcare Conference. Fireside chat on Tuesday, December 3 at 1:45 p.m. ET in Miami, FL.
- 7th Annual Evercore I&I HealthCONx Conference. Fireside chat on Wednesday, December 4 at 1:45 p.m. ET in Coral Gables, FL.
- Piper Sandler’s 35th Annual Healthcare Conference. Fireside chat on Thursday, December 5 at 9:00 a.m. ET in New York, NY.
Additional information regarding these events will be available on the Investors section of the argenx website at argenx.com/investors.
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker, globally in the U.S., Japan, Israel, the EU, the UK, China and Canada. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, X/Twitter, Instagram, Facebook, and YouTube.
For further information, please contact:
Media:
Ben Petok
bpetok@argenx.com
Investors:
Alexandra Roy (US)
aroy@argenx.com
Lynn Elton (EU)
lelton@argenx.com
FAQ
What investor conferences will argenx (ARGX) attend in December 2024?
When is argenx (ARGX) presenting at Citi's 2024 Global Healthcare Conference?
Where can investors find additional information about argenx's (ARGX) conference presentations?
